Artificial 'inclusion bodies' created for controlled drug release

A new study describes the development of a new biomaterial with sustained drug release. The results describe the creation of artificial inclusion bodies for uses in precision biotechnology and nanomedicine. The structures contain functional proteins released similarly to how human hormones are released by the endocrine system.